M. G.
- Country
- The Netherlands
- Department
- interne oncologie
Research Overview
- Phase I Study of BI 764532 Dose Tolerability in Patients with DLL3-Positive Glioma
- Evaluation of CVGBM Vaccine Efficacy and Safety in Patients with Surgically Resected Glioblastoma or Astrocytoma with Unmethylated Glioblastoma Signature
- Phase I/II Evaluation of NMS-03305293 and Temozolomide in Adult Patients with Recurrent Glioblastoma
Data & Insights
Has run more than one trial at 22 of 82 partner sites.
Specializations
Primary Brain Tumors
The investigator specializes in treating various types of malignant brain tumors, with particular expertise in glioblastoma and astrocytoma management. Their research encompasses both newly diagnosed and recurrent cases.
- Glioblastoma Treatment
- IDH-Mutant Gliomas
- Recurrent Brain Tumors
Their work includes evaluation of innovative therapeutic approaches for patients with molecular-specific tumor variants.
Treatment Modalities
The investigator focuses on developing combination therapy approaches, integrating various treatment methods including chemotherapy and radiation therapy. They explore novel therapeutic combinations to enhance treatment outcomes.
- Targeted Molecular Therapies
- Re-irradiation Strategies
- Immunotherapy Approaches
Their research includes evaluation of novel drug combinations and innovative delivery systems for brain tumor treatment.
Precision Medicine
The investigator's work centers on personalized treatment approaches based on specific molecular markers, including DLL3 expression and IDH mutation status in brain tumors.
- Molecular Profiling
- Biomarker-Driven Therapy
- Vaccine Development
Their research explores tailored therapeutic strategies based on individual tumor characteristics and molecular signatures.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.